Evaluation of the AID TB resistance line probe assay for rapid detection of genetic alterations associated with drug resistance in Mycobacterium tuberculosis strains

Journal of Clinical Microbiology

Volumn 52, Issue 3, 2014, Pages 940-946

  Ritter, C ^a,b   Lucke, K ^a,b   Sirgel, F A ^c   Warren, R W ^c   Van Helden, P D ^c   Bottger E C ^a,b   Bloemberg, G V ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Nationales Zentrum fur Mykobakterien   (Switzerland)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ETHAMBUTOL; ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BROTH DILUTION; DIAGNOSTIC TEST; DNA EXTRACTION; DNA HYBRIDIZATION; DNA SEQUENCE; ENDEMIC DISEASE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PHENOTYPE; PRIORITY JOURNAL; SOUTH AFRICA; SWITZERLAND; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SWITZERLAND;

EID: 84894594015     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02597-13     Document Type: Article

References (30)

1. World Health Organization. 2011. WHO report 2011: global tuberculosis control. WHO/HTM/TB/2011.16. WHO, Geneva, Switzerland.
2. World Health Organization. 2006. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly. Epidemiol. Rec. 81:430-432.
3. Böttger EC. 2011. The ins and outs of Mycobacterium tuberculosis drug susceptibility testing. Clin. Microbiol. Infect. 17:1128-1134. http://dx.doi.org/10.1111/j.1469-0691.2011.03551.x.
4. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. 2005. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 43:3699-3703. http://dx.doi.org/10.1128/JCM.43.8.3699-3703.2005. (Pubitemid 41129648)
5. Hillemann D, Rüsch-Gerdes S, Richter E. 2009. Feasibility of the Geno-Type MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 47:1767-1772. http://dx.doi.org/10.1128/JCM. 00081-09.
6. Jacobson KR, Theron D, Kendall EA, Franke MF, Barnard M, van Helden PD, Victor TC, Streicher EM, Murray MB, Warren RM. 2013. Implementation of genotype MTBDRplus reduces time to multidrugresistant tuberculosis therapy initiation in South Africa. Clin. Infect. Dis. 56:503-508. http://dx.doi.org/10.1093/cid/ cis920.
7. Barnard M, Warren R, Van Pittius NG, van Helden P, Bosman M, Streicher E, Coetzee G, O'Brien R. 2012. Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory. Am. J. Respir. Crit. Care Med. 186:1298-1305. http://dx.doi.org/10.1164/rccm.201205-0960OC.
8. Kontsevaya I, Ignatyeva O, Nikolayevskyy V, Balabanova Y, Kovalyov A, Kritsky A, Matskevich O, Drobniewski F. 2013. Diagnostic accuracy of the genotype MTBDRsl assay for rapid diagnosis of extensively drugresistant tuberculosis in HIV-coinfected patients. J. Clin. Microbiol. 51: 243-248. http://dx.doi.org/10.1128/JCM.02513-12.
9. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015. http://dx.doi.org/10.1056/NEJMoa0907847.
10. Zbinden A, Keller PM, Bloemberg GV. 2011. Rapid molecular detection of tuberculosis. N. Engl. J. Med. 364:183. http://dx.doi.org/10.1056/ NEJMc1011919#SA3.
11. Somoskovi A, Deggim V, Ciardo D, Bloemberg GV. 2013. Diagnostic implications of inconsistent results obtained with the Xpert MTB/Rif assay in detection of Mycobacterium tuberculosis isolates with an rpoB mutation associated with low-level rifampin resistance. J. Clin. Microbiol. 51:3127-3129. http://dx.doi.org/10.1128/JCM.01377-13.
12. Rossau R, Traore H, De Beenhouwer H, Mijs W, Jannes G, De Rijk P, Portaels F. 1997. Evaluation of the INNO-LiPA Rif.TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob. Agents Chemother. 41:2093-2098. (Pubitemid 27422196)
13. Engström A, Morcillo N, Imperiale B, Hoffner SE, Juréen P. 2012. Detection of first-and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing. J. Clin. Microbiol. 50:2026-2033. http://dx.doi.org/10.1128/JCM.06664-11.
14. Lacoma A, García-Sierra N, Prat C, Maldonado J, Ruiz-Manzano J, Haba L, Gavin P, Samper S, Ausina V, Domínguez J. 2012. GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples. J. Clin. Microbiol. 50:30-36. http://dx.doi.org/10.1128/JCM.05274-11.
15. Kent PT, Kubica GP. 1985. Public health mycobacteriology: a guide for the level III laboratory. Centers for Disease Control and Prevention, Atlanta, GA.
16. IsenbergHD(ed). 1992. Clinical microbiology procedures handbook, vol 1. American Society for Microbiology, Washington, DC.
17. Roche Diagnostics. 2009. Cobas Taqman Mycobacterium tuberculosis test: instruction manual. Roche Diagnostics, Mannheim, Germany.
18. Kirschner P, Rosenau J, Springer B, Teschner K, Feldmann K, Böttger EC. 1996. Diagnosis of mycobacterial infections by nucleic acid amplification: 18-month prospective study. J. Clin. Microbiol. 34:304-312.
19. Lipin MY, Stepanshina VN, Shemyakin IG, Shinnick TM. 2007. Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. Clin. Microbiol. Infect. 13:620-626. http://dx.doi.org/10.1111/j.1469-0691.2007.01711. x. (Pubitemid 46730669)
20. Leung ET, Ho PL, Yuen KY, Woo WL, Lam TH, Kao RY, Seto WH, Yam WC. 2006. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. Antimicrob. Agents Chemother. 50:1075-1078. http://dx.doi.org/10.1128/AAC.50.3.1075-1078.2006. (Pubitemid 43328883)
21. Yue J, Shi W, Xie J, Li Y, Zeng E, Wang H. 2003. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol. 41:2209-2212. http://dx.doi.org/10.1128/JCM.41.5.2209-2212. 2003. (Pubitemid 36576568)
22. Finken M, Kirschner P, Meier A, Wrede A, Böttger EC. 1993. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol. Microbiol. 9:1239-1246. http://dx.doi.org/10. 1111/j.1365-2958.1993.tb01253.x. (Pubitemid 23286255)
23. Baker L, Brown T, Maiden MC, Drobniewski F. 2004. Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis. Emerg. Infect. Dis. 10:1568-1577. http://dx.doi.org/10.3201/eid1009.040046. (Pubitemid 39201508)
24. Pfister P, Hobbie S, Brüll C, Corti N, Vasella A, Westhof E, Böttger EC. 2005. Mutagenesis of 16S rRNA C1402-G1484 base-pair differentiates between6'OH and 6'NH3+ aminoglycosides. J. Mol. Biol. 346:467-475. http://dx.doi.org/10.1016/j.jmb.2004.11.073.
25. Akbergenov R, Shcherbakov D, Matt T, Duscha S, Meyer M, Wilson DN, Böttger EC. 2011. Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin. Antimicrob. Agents Chemother. 55:4712-4717. http://dx.doi.org/10.1128/AAC.00628-11.
26. Johnson R, Jordaan AM, Pretorius L, Engelke E, van der Spuy G, Kewley C, Bosman M, van Helden PD, Warren R, Victor TC. 2006. Ethambutol resistance testing by mutation detection. Int. J. Tuberc. Lung Dis. 10:68-73. (Pubitemid 43266280)
27. Weber W, Schoenmakers R, Keller B, Gitzinger M, Grau T, Daoud-El Baba M, Sander P, Fussenegger M. 2008. A synthetic mammalian gene circuit reveals antituberculosis compounds. Proc. Natl. Acad. Sci. U. S. A. 105:9994-9998. http://dx.doi.org/10.1073/pnas.0800663105.
28. Springer B, Lucke K, Calligaris-Maibach R, Ritter C, Böttger EC. 2009. Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation. J. Clin. Microbiol. 47: 1773-1780. http://dx.doi.org/10.1128/JCM.02501-08.
29. Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC. 2003. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 47:3799-3805. http://dx.doi.org/10. 1128/AAC.47.12.3799-3805.2003. (Pubitemid 37484992)
30. Böttger EC, Springer B. 2009. Mycobacterium tuberculosis: drug resistance and genetic mechanisms - facts, artifacts and fallacies, p 103-121. In Kaufmann SHE, Walker B (ed), HIV and tuberculosis: a deadly liaison. Wiley-VCH, Weinheim, Germany.